The role of phospholipids
In antiphospholipid syndrome, your body mistakenly produces antibodies against proteins that bind phospholipids, a type of fat present in your blood that plays a key role in clotting (coagulation). Antibodies are specialized proteins that normally attack body invaders, such as viruses and bacteria. When antibodies attack your phospholipid-binding proteins, your blood may clot abnormally.
There are two main classifications of antiphospholipid syndrome:
- Primary. If there's no known underlying reason, such as an autoimmune disorder, you have primary antiphospholipid syndrome.
- Secondary. If you have systemic lupus erythematosus or another autoimmune disorder, certain infections, or have taken certain medications, your antiphospholipid syndrome is secondary. The cause of your antiphospholipid syndrome is considered to be the underlying condition or medication.
Some factors are associated with developing antiphospholipid antibodies — though not necessarily with developing the syndrome. They include:
April 15, 2014
- Infections. People with certain infections, including syphilis, HIV infection, hepatitis C and Lyme disease, among others, have a higher incidence of having antiphospholipid antibodies.
- Medications. The high blood pressure medication hydralazine, the heart rhythm-regulating medication quinidine, the anti-seizure medication phenytoin (Dilantin) and the antibiotic amoxicillin may lead to an increased risk of developing antiphospholipid antibodies.
- Genetic predispositions. Although the disorder isn't considered hereditary, research indicates that relatives of people with antiphospholipid syndrome are more likely to have the antibodies.
- Giannakopoulos B, et al. Pathogenesis of the antiphospholipid syndrome. New England Journal of Medicine. 2013;368:1033.
- What is antiphospholipid antibody syndrome? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/aps/. Accessed Dec. 2, 2013.
- Learning about antiphospholipid syndrome. National Human Genome Research Institute. http://www.genome.gov/pfv.cfm?pageID=17516396. Accessed Dec. 4, 2013.
- Papadakis MA, et al. Current Medical Diagnosis & Treatment 2013. 52nd ed. New York, N.Y.: The McGraw-Hill Companies; 2013. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=1. Accessed Dec. 4, 2013.
- Bermas BL, et al. Pathogenesis of the antiphospholipid syndrome. http://www.uptodate.com/home. Accessed Dec. 5, 2013.
- Donadini MP, et al. Antiphospholipid syndrome: A challenging hypercoagulable state with systemic manifestations. Hematology/Oncology Clinics of North America. 2010;24:669.
- Arnaud L, et al. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis. Autoimmunity Reviews. 2013 [In Press]. Accessed Dec. 4, 2013.
- Bermas BL, et al. Treatment of the antiphospholipid syndrome. http://www.uptodate.com/home. Accessed Dec. 4, 2013.
- Lockshin MD. Pregnancy and antiphospholipid syndrome. American Journal of Reproductive Immunology. 2013;69:585.
- Wijetilleka S, et al. Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome. Current Opinion in Rheumatology. 2012;24:473.
- Arachchillage AJ, et al. Use of new oral anticoagulants in antiphospholipid syndrome. Current Rheumatology Report. 2013;15:331.
- Blood thinner pills: Your guide to using them safely. Rockville, Md.: Agency for Healthcare Research and Quality. http://www.ahrq.gov/consumer/btpills.htm. Accessed Dec. 5, 2013.
- Dietary Reference Intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Institute of Medicine. http://www.iom.edu/Reports/2001/Dietary-Reference-Intakes-for-Vitamin-A-Vitamin-K-Arsenic-Boron-Chromium-Copper-Iodine-Iron-Manganese-Molybdenum-Nickel-Silicon-Vanadium-and-Zinc.aspx. Accessed Dec. 5, 2013.
You Are ... The Campaign for Mayo Clinic
Mayo Clinic is a not-for-profit organization. Make a difference today.